Yemen Supreme National Emergency Committee for COVID-19 Daily Report 2021 Epi surveillance GHDx Entry last modified on: Aug 24, 2023
Eswatini COVID-19 Rapid Gender Assessment Survey 2021 Survey: Cross-sectional - Individual - Interview GHDx Entry last modified on: Oct 23, 2024
CDC Ebola Cases and Outbreaks by Year 2021 Cases and Outbreaks of EVD by Year 2021 Epi surveillance GHDx Entry last modified on: May 31, 2023
Associations between reported post-COVID-19 symptoms and subjective well-being, Israel, July 2021 - April 2022 Scientific literature GHDx Entry last modified on: Mar 22, 2024
Post-COVID syndrome: A prospective study in a tertiary hospital of Nepal Scientific literature GHDx Entry last modified on: Mar 22, 2024
Canada - COVID-19 Data in Quebec 2021 Données COVID-19 au Québec Epi surveillance GHDx Entry last modified on: Aug 1, 2022
Bhutan Royal Centre for Disease Control Quarterly Bulletin: First Quarter, Volume 25, January-March 2021 RCDC 1st Quarterly Bulletin Volume 25, Jan -March 2021 Epi surveillance: Subnationally representative GHDx Entry last modified on: Jan 17, 2023
United States National Health Interview Survey 2021 2021 NHIS Survey: Cross-sectional - Household - Individual - Interview - Nationally representative GHDx Entry last modified on: Oct 18, 2024
Three-month Clinical Status of A Cohort of Adult Hospitalized COVID-19 Pimpaka Srisiriwanna M.D., Poolsuk Janepanish Visudtibhan Ph.D., Kumthorn Malathum M.D Scientific literature GHDx Entry last modified on: Mar 22, 2024
Prevalence and associating factors of long COVID in pediatric patients during the Delta and the Omicron variants Scientific literature GHDx Entry last modified on: Mar 22, 2024
COVID-19 Vaccination and Case Trends by Age Group, United States 2020-2022 Archive: COVID-19 Vaccination and Case Trends by Age Group, United States Administrative data: Epi surveillance GHDx Entry last modified on: May 1, 2024
WHO Pulse Survey on Continuity of Essential Health Services During the COVID-19 Pandemic 2020-2021 - Round 2 Survey GHDx Entry last modified on: Aug 4, 2023
Covid-19 Vaccination Strategy In Spain 2020-2022 Estrategia De Vacunación Covid-19 En Espana Epi surveillance GHDx Entry last modified on: Aug 24, 2023
Italy Open Data on COVID-19 Vaccines 2020-2022 covid19-opendata-vaccini, Open Data su consegna e somministrazione dei vaccini anti COVID-19 in Italia Epi surveillance GHDx Entry last modified on: Aug 24, 2023
Prevalence of SARS-CoV-2 antibodies in Denmark 2020: results from nationwide, population-based sero-epidemiological surveys. Preprint Scientific literature GHDx Entry last modified on: May 12, 2022
Mongolia Multiple Indicator Cluster Survey Plus 2020-2021, Wave 2 2020 Mongolia MICS Plus 2020 Wave 2 Survey: Household - Individual - Interview - Longitudinal - Nationally representative - Urban-rural representative GHDx Entry last modified on: Sep 22, 2024
High Seroprevalence of SARS-CoV-2 Eight Months After Introduction in Nairobi, Kenya. Preprint Scientific literature GHDx Entry last modified on: May 12, 2022
Colombia COVID-19 Rapid Gender Assessment Survey 2020 Survey: Cross-sectional - Individual GHDx Entry last modified on: Oct 23, 2024
Malawi COVID-19 Rapid Gender Assessment Survey 2020 Survey: Cross-sectional - Individual - Interview GHDx Entry last modified on: Oct 23, 2024
Serum-epidemiological Survey of SARS-CoV-2, Cities of Xai-Xai and Chókwè (InCOVID 2020) - Preliminary Results Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Xai-Xai e Chókwè (InCOVID 2020) - Resultados Preliminares - Epi surveillance GHDx Entry last modified on: Aug 2, 2022
Puerto Rico Community Assessment for Response to Public Health Emergencies (CASPER) 2020 Evaluación Comunitaria para la Respuesta a Emergencias de Salud Pública (CASPER) Survey: Epi surveillance GHDx Entry last modified on: May 12, 2022
South Africa COVID-19 Special Public Health Surveillance Bulletin, Volume 18 Supplementary Issue 9, 12 March 2021 COVID-19 Special Public Health Surveillance Bulletin Volume 18 (Issue 9: 12 Mar 2021) Epi surveillance: Cross-sectional - Individual GHDx Entry last modified on: Sep 9, 2022
33.98% of Tripura has COVID-19 antibody in them, shows sero survey Survey: Epi surveillance GHDx Entry last modified on: May 12, 2022
Australia Household Impacts of Covid-19 Survey November 2020 Survey: Longitudinal GHDx Entry last modified on: Jan 25, 2023
Canada - British Columbia COVID-19 Situation Report 2020-2022 British Columbia (BC) COVID-19 Situation Report Epi surveillance GHDx Entry last modified on: Aug 24, 2023
Seroprevalence of antibodies against SARS-CoV-2 virus in the adult Norwegian population, winter 2020/2021: pre-vaccination period. Preprint Scientific literature GHDx Entry last modified on: May 12, 2022
SARS-CoV-2 infection and transmission in school settings during the second wave in Berlin, Germany: a cross-sectional study. Preprint Scientific literature GHDx Entry last modified on: Mar 14, 2022
Spain - Catalonia COVID-19 Weekly Confirmed Cases and Deaths 2020-2022 Incidència setmanal de la covid-19 Epi surveillance GHDx Entry last modified on: Aug 24, 2023
Nepal National Sero-Prevalence Survey for COVID-19 2020 Round 1 ENHANCED SURVEILLANCE ON SERO-PREVALENCE OF SARS-COV-2 IN GENERAL POPULATION Survey GHDx Entry last modified on: May 12, 2022
Brazil - Maranhão Prevalence of SARS-CoV-2 Virus Infection Survey 2020 Phase II Prevalência de infecção pelo vírus SARS-CoV-2 no Maranhão, segunda fase Survey: Individual - Interview GHDx Entry last modified on: Oct 21, 2022
Brazil - Sao Paulo Household Survey to Estimate the Seroprevalence of SARS-CoV-2 Infection, 2020, Phase 4 (SoroEpi MSP) Avaliação da prevalência da infecção pelo vírus SARS-CoV-2 em habitantes do município de São Paulo: Resultados Parciais da Fase 4 Survey GHDx Entry last modified on: May 17, 2024
Bhutan Royal Centre for Disease Control Quarterly Disease Surveillance Bulletin: Fourth Quarter, October-December 2020 RCDC Surveillance Bullletin, Volume 24, 4th Quarter 2020 (1st Quarter to 30 December) 2020 Epi surveillance: Subnationally representative GHDx Entry last modified on: Aug 6, 2021
4.7% of the Austrian population had antibodies against SARS-CoV -2 in mid / late October Epi surveillance GHDx Entry last modified on: May 12, 2022
Uganda COVID-19 Rapid Gender Assessment Survey 2020 Survey: Cross-sectional - Individual - Interview GHDx Entry last modified on: Oct 23, 2024
India - Haryana Covid-19 Sero Survey Round 2, October 2020 Sero-prevalence of Anti-SARS-CoV-2 IgG antibodies in Haryana, India: A Population based Cross-Sectional Study (2nd Round) Survey: Cross-sectional - Epi surveillance - Urban-rural representative GHDx Entry last modified on: May 12, 2022
Mali COVID-19 Rapid Gender Assessment Survey 2020 Survey: Cross-sectional - Individual - Interview GHDx Entry last modified on: Oct 23, 2024
South Africa COVID-19 Rapid Gender Assessment Survey 2020 Survey: Individual - Interview GHDx Entry last modified on: Oct 24, 2024
Mozambique COVID-19 Rapid Gender Assessment Survey 2020 Survey: Cross-sectional - Individual - Interview GHDx Entry last modified on: Oct 23, 2024
India - Jharkhand Regional Outreach Bureau Twitter Communications and COVID-19 Updates 2020-2021 Epi surveillance GHDx Entry last modified on: Aug 25, 2023
20% of Andhra Exposed to Covid, Sero-survey Finds, Exposure Highest Where Case Tally Lowest Survey: Cross-sectional - Epi surveillance - Urban only GHDx Entry last modified on: Aug 1, 2022
Chile COVID-19 Rapid Gender Assessment Survey 2020 Survey: Cross-sectional - Individual GHDx Entry last modified on: Oct 23, 2024
Population-based seroprevalence of SARS-CoV-2 antibodies in a high-altitude setting in Peru. Preprint Scientific literature GHDx Entry last modified on: May 12, 2022
Mexico COVID-19 Rapid Gender Assessment Survey 2020 Survey: Cross-sectional - Individual GHDx Entry last modified on: Oct 23, 2024
Ethiopia COVID-19 Rapid Gender Assessment Survey 2020 Survey: Cross-sectional - Individual - Interview GHDx Entry last modified on: Oct 23, 2024
Guinea COVID-19 Rapid Gender Assessment Survey 2020 Survey: Cross-sectional - Individual - Interview GHDx Entry last modified on: Oct 23, 2024
Serum-epidemiological Survey of SARS-CoV-2, City of Lichinga (InCOVID 2020) - Preliminary Results Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Lichinga (InCOVID 2020) - Resultados Preliminares - Epi surveillance GHDx Entry last modified on: Aug 2, 2022
Serum-epidemiological Survey of SARS-CoV-2, City of Beira (InCOVID 2020) - Preliminary Results Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Beira (InCOVID 2020) - Resultados Preliminares - Epi surveillance GHDx Entry last modified on: Aug 2, 2022
Serum-epidemiological Survey of SARS-CoV-2, City of Tete (InCOVID 2020) - Preliminary Results Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Tete (InCOVID 2020) - Resultados Preliminares - Epi surveillance GHDx Entry last modified on: Aug 2, 2022
Seroprevalence of SARS-CoV-2 Infection Among Occupational Groups from Bucaramanga Metropolitan Area, Colombia. Preprint Scientific literature GHDx Entry last modified on: Oct 5, 2022